PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kim J et al. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. 2005 Cancer Res. pmid:16024620
Polikandriotis JA et al. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:16020752
Matsuzaki Y et al. 15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. 2005 Int. J. Oncol. pmid:16010433
Eggler AL et al. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16006525
Pande V and Ramos MJ Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins. 2005 Bioorg. Med. Chem. Lett. pmid:16006125
Kim HJ et al. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes. 2005 Exp. Mol. Med. pmid:16000871
Honma Y et al. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. 2005 Eur. J. Pharmacol. pmid:16000196
Chacón P et al. Induction of cyclooxygenase-2 expression by allergens in lymphocytes from allergic patients. 2005 Eur. J. Immunol. pmid:15997464
Zurich MG et al. Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. 2005 Neuroscience pmid:15994020
Patel KM et al. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). 2005 Cell. Signal. pmid:15993751
Costello DA et al. Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro. 2005 Neuropharmacology pmid:15993441
Kaplan JM et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. 2005 Shock pmid:15988322
Núñez NP et al. PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. 2006 Cancer Lett. pmid:15979236
Hogaboam CM et al. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. 1992 Br. J. Pharmacol. pmid:1596692
Ibabe A et al. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. 2005 Toxicol In Vitro pmid:15964169
Wang D et al. Terbutaline acts at multiple sites to inhibit bronchoconstriction induced by dry air in canine peripheral airways. 1992 Am. Rev. Respir. Dis. pmid:1595994
Tomita H et al. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. 2005 Cardiovasc. Res. pmid:15949477
Kunkel SL et al. Suppression of immune complex vasculitis in rats by prostaglandin. 1979 J. Clin. Invest. pmid:159314
D'Onofrio C et al. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells. 1992 Int. J. Cancer pmid:1592539
Hosoya T et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. 2005 J. Biol. Chem. pmid:15917255
Hennersdorf F et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. 2005 Cell Res. pmid:15916720
Ishida A et al. Characterization of cAMP-dependent proteolysis of GATA-6. 2005 Biochem. Biophys. Res. Commun. pmid:15913546
Wang Z and Figueiredo-Pereira ME Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity. 2005 Mol. Cell. Neurosci. pmid:15911346
Avis I et al. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. 2005 Cancer Res. pmid:15899809
Capobianco E et al. 15-Deoxy-Delta12,14-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism. 2005 Reprod. Fertil. Dev. pmid:15899154
Malki S et al. Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. 2005 EMBO J. pmid:15889150
Artwohl M et al. Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells. 2005 Thromb. Haemost. pmid:15886792
Martín AR et al. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice. 2005 Inflamm. Res. pmid:15883736
Marchini C et al. Aspirin modulates LPS-induced nitric oxide release in rat glial cells. 2005 Jun 10-17 Neurosci. Lett. pmid:15882795
Raible DG et al. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. 1992 J. Immunol. pmid:1588043
Hashimoto Y et al. Prostaglandin D2 inhibits IgE-mediated scratching by suppressing histamine release from mast cells. 2005 J. Pharmacol. Sci. pmid:15879676
Blanco M et al. Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. 2005 Stroke pmid:15879329
Kim HY et al. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages. 2005 Immunol. Cell Biol. pmid:15877607
Planagumà A et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. 2005 FASEB J. pmid:15876570
De Oliveira C et al. Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells. 2005 J. Lab. Clin. Med. pmid:15871306
Li X et al. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. 2005 J. Rheumatol. pmid:15868626
Yoshida M et al. Methotrexate suppresses inflammatory agonist induced interleukin 6 synthesis in osteoblasts. 2005 J. Rheumatol. pmid:15868610
Maurin AC et al. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. 2005 Calcif. Tissue Int. pmid:15868283
Marzocco S et al. The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. 2005 Intensive Care Med pmid:15868139
Allred CD and Kilgore MW Selective activation of PPARgamma in breast, colon, and lung cancer cell lines. 2005 Mol. Cell. Endocrinol. pmid:15866424
Andrews WJ et al. Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production. 2005 J. Steroid Biochem. Mol. Biol. pmid:15862961
Saito H [Mast cells]. 2005 Nippon Rinsho pmid:15861652
Kämpfer H et al. Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. 2005 Diabetes pmid:15855344
Drew PD et al. Hormone regulation of microglial cell activation: relevance to multiple sclerosis. 2005 Brain Res. Brain Res. Rev. pmid:15850670
Ninomiya H et al. Endothelin-1 induces stimulation of prostaglandin synthesis in cells obtained from canine airways by bronchoalveolar lavage. 1992 Prostaglandins pmid:1584994
Ackerman WE et al. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. 2005 Biol. Reprod. pmid:15843495
Chen YC et al. Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. 2005 Biochim. Biophys. Acta pmid:15843042
Mitchell MD et al. Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. 2005 J. Clin. Endocrinol. Metab. pmid:15840748
Ji JD et al. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. 2005 Rheumatology (Oxford) pmid:15840591
Liu J et al. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. 2005 Cancer Chemother. Pharmacol. pmid:15838654
Berry EB et al. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. 2005 Mol. Pharmacol. pmid:15821150
Sanchez-Rodriguez J et al. The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells. 2005 Biochem. J. pmid:15819613
Inoue K et al. Effects of 15-deoxy-delta(12,14)-prostaglandin J2 on nuclear localization of GATA-3 in the murine lung in the presence of lipopolysaccharide. 2005 Arzneimittelforschung pmid:15819389
PPAR activators and gastroenterology. 2004 Drug News Perspect. pmid:15801147
Masuko-Hongo K [Role of prostaglandins in rheumatoid arthritis]. 2005 Nippon Rinsho pmid:15799333
Dore-Duffy P et al. The CNS pericyte response to low oxygen: early synthesis of cyclopentenone prostaglandins of the J-series. 2005 Microvasc. Res. pmid:15797264
Fowler CJ and Tiger G Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro. 2005 Biochem. Pharmacol. pmid:15794945
Gazi L et al. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. 2005 Prostaglandins Other Lipid Mediat. pmid:15789622
Marshall JC Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? 2005 Intensive Care Med pmid:15782317
Kim S et al. Synthesis of 15R-PGD2: a potential DP2 receptor agonist. 2005 Bioorg. Med. Chem. Lett. pmid:15780624
Yuan J et al. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma. 2005 Urology pmid:15780399
Yuan Z et al. Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. 2005 Heart pmid:15774612
Viñals M et al. Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. 2005 Cardiovasc. Res. pmid:15769457
Gallant MA et al. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. 2005 J. Bone Miner. Res. pmid:15765187
Pataki I et al. In vivo effects of isatin on rat platelet eicosanoids. 2005 Platelets pmid:15763895
Takashima T et al. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. 2005 Oncol. Rep. pmid:15756430
Lindström TM and Bennett PR 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. 2005 J. Clin. Endocrinol. Metab. pmid:15755849
Moulin D et al. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. 2005 Arthritis Rheum. pmid:15751073
Mochizuki M et al. Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. 2005 Am. J. Respir. Crit. Care Med. pmid:15750045
Spik I et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. 2005 J. Immunol. pmid:15749909
Storer PD et al. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. 2005 J. Neuroimmunol. pmid:15748950
Usui S et al. Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2. 2005 Bioorg. Med. Chem. Lett. pmid:15745794
Inoue K et al. Effects of 15-deoxy-Delta12,14-prostaglandin J2 on the expression of Toll-like receptor 4 and 2 in the murine lung in the presence of lipopolysaccharide. 2005 Clin. Exp. Pharmacol. Physiol. pmid:15743408
Burgess HA et al. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. 2005 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:15734787
Sasaguri T et al. Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. 1992 Exp. Cell Res. pmid:1572402
Storer PD et al. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. 2005 J. Neurosci. Res. pmid:15723383
Takagi T et al. A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats. 2004 Redox Rep. pmid:15720836
Higashihara H et al. Hypoxia-reoxygenation enhances interleukin-8 production from U937 human monocytic cells. 2004 Redox Rep. pmid:15720834
García-Bueno B et al. The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. 2005 Psychopharmacology (Berl.) pmid:15719215
Bulló M et al. Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15713689
Shiraki T et al. Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. 2005 J. Biol. Chem. pmid:15695504
Shen ZN et al. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21. 2005 Biochem. Biophys. Res. Commun. pmid:15694358
Genovese T et al. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. 2005 Eur. Respir. J. pmid:15684285
Tanaka T et al. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. 2005 Eur. J. Pharmacol. pmid:15680279
Figarella K et al. Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form. 2005 Cell Death Differ. pmid:15678148
Jerde TJ et al. Celecoxib inhibits ureteral contractility and prostanoid release. 2005 Urology pmid:15667901
Lee KJ et al. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g. 2004 Exp. Mol. Med. pmid:15665586
O'Reilly KM et al. Crystalline and amorphous silica differentially regulate the cyclooxygenase-prostaglandin pathway in pulmonary fibroblasts: implications for pulmonary fibrosis. 2005 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:15665045
Trottein F et al. Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses. 2004 Crit. Rev. Immunol. pmid:15663363
Blázovics A et al. [Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases]. 2004 Orv Hetil pmid:15662752
Migita H and Morser J 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:15662020
Liang X et al. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. 2005 J. Neurochem. pmid:15659218
Martínez B et al. The mitochondrial respiratory complex I is a target for 15-deoxy-delta12,14-prostaglandin J2 action. 2005 J. Lipid Res. pmid:15654126
Motilva V et al. COX expression and PGE(2) and PGD(2) production in experimental acute and chronic gastric lesions. 2005 Int. Immunopharmacol. pmid:15652766
Liu JJ et al. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro. 2005 Ann. Oncol. pmid:15642706
Farrajota K et al. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. 2005 Arthritis Rheum. pmid:15641079
Scher JU and Pillinger MH 15d-PGJ2: the anti-inflammatory prostaglandin? 2005 Clin. Immunol. pmid:15639643
López-Parra M et al. The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin. 2005 J. Hepatol. pmid:15629510
Chou YH et al. The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. 2005 Int. J. Biochem. Cell Biol. pmid:15618017
Inoue K et al. Effects of 15-deoxy-delta12,14-prostaglandin J2 on the cyclooxygenase-2 expression in the murine lung in the presence of lipopolysaccharide. 2004 Arzneimittelforschung pmid:15612612